BLUA vs. KRMD, BWAY, MGRM, ALUR, DCTH, STIM, TELA, NVNO, ICCM, and SEPA
Should you be buying BlueRiver Acquisition stock or one of its competitors? The main competitors of BlueRiver Acquisition include KORU Medical Systems (KRMD), BrainsWay (BWAY), Monogram Orthopaedics (MGRM), Allurion Technologies (ALUR), Delcath Systems (DCTH), Neuronetics (STIM), TELA Bio (TELA), enVVeno Medical (NVNO), IceCure Medical (ICCM), and SEP Acquisition (SEPA). These companies are all part of the "surgical & medical instruments" industry.
KORU Medical Systems (NASDAQ:KRMD) and BlueRiver Acquisition (NYSE:BLUA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, community ranking, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.
58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 22.3% of BlueRiver Acquisition shares are held by institutional investors. 25.6% of KORU Medical Systems shares are held by insiders. Comparatively, 79.0% of BlueRiver Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
BlueRiver Acquisition has lower revenue, but higher earnings than KORU Medical Systems.
KORU Medical Systems currently has a consensus price target of $3.50, suggesting a potential upside of 56.95%. Given BlueRiver Acquisition's higher probable upside, equities analysts plainly believe KORU Medical Systems is more favorable than BlueRiver Acquisition.
In the previous week, KORU Medical Systems had 1 more articles in the media than BlueRiver Acquisition. MarketBeat recorded 2 mentions for KORU Medical Systems and 1 mentions for BlueRiver Acquisition. KORU Medical Systems' average media sentiment score of 0.00 beat BlueRiver Acquisition's score of -0.33 indicating that BlueRiver Acquisition is being referred to more favorably in the news media.
BlueRiver Acquisition has a net margin of 0.00% compared to BlueRiver Acquisition's net margin of -48.18%. KORU Medical Systems' return on equity of 0.00% beat BlueRiver Acquisition's return on equity.
KORU Medical Systems received 36 more outperform votes than BlueRiver Acquisition when rated by MarketBeat users.
Summary
KORU Medical Systems beats BlueRiver Acquisition on 7 of the 12 factors compared between the two stocks.
Get BlueRiver Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for BLUA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BLUA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BlueRiver Acquisition Competitors List
Related Companies and Tools
